Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Revenue (2016 - 2025)

Historic Revenue for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $33.3 million.

  • Xtant Medical Holdings' Revenue rose 1903.57% to $33.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.1 million, marking a year-over-year increase of 1688.2%. This contributed to the annual value of $117.3 million for FY2024, which is 2843.72% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Revenue stood at $33.3 million for Q3 2025, which was up 1903.57% from $35.4 million recorded in Q2 2025.
  • Xtant Medical Holdings' Revenue's 5-year high stood at $35.4 million during Q2 2025, with a 5-year trough of $12.5 million in Q1 2021.
  • Moreover, its 5-year median value for Revenue was $20.2 million (2023), whereas its average is $22.3 million.
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 1513.06% in 2021, then soared by 8407.33% in 2023.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Revenue stood at $14.0 million in 2021, then grew by 9.31% to $15.3 million in 2022, then soared by 84.07% to $28.1 million in 2023, then rose by 12.11% to $31.5 million in 2024, then increased by 5.53% to $33.3 million in 2025.
  • Its Revenue was $33.3 million in Q3 2025, compared to $35.4 million in Q2 2025 and $32.9 million in Q1 2025.